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An unmatched characteristic of the liver is the ability to rebuild its lost mass either after toxic 
tissue damage or liver resection.1 The latter is a well-established surgical technique, known 
as partial hepatectomy in which up to 70% of the entire liver can be removed.1,2 Partial 
hepatectomy is used clinically as a treatment strategy for primary and selected metastatic 
liver cancers, and experimentally as a stimulus to study liver regeneration.3 The main 
drawback of partial hepatectomy, however, is that not all patients with liver disease are 
candidates for liver resection. Indeed, in many clinical scenarios liver regeneration is not 
sufficient to circumvent loss of a large volume of hepatic tissue, with detrimental effects on 
the survival of the recovering patient.3,4 It is now appreciated that liver regeneration involves 
compensatory growth followed by proliferation of all adult cells that compose the liver 
including hepatocytes, sinusoidal endothelial cells, biliary epithelial cells, Kupffer cells and 
hepatic stellate cells (HSCs).1,2 Although the mechanisms behind the failure of liver 
regeneration are not entirely clear, research in the field has aided the development of a new 
surgical procedure to promote an accelerated liver regeneration,5,6 opening up the benefits of 
liver resection to the wider populations of patients undergoing extensive liver resection. 
Indeed, a two-stage hepatectomy – also known as associating liver partition and portal vein 
ligation (PVL) in staged hepatectomy (ALPPS) – is routinely adopted in the clinic to 
accelerate liver regeneration.5,6 While the ALPPS-mediated hepatic regeneration process is 
histologically well described,5,6 the signalling pathways that orchestrate the acceleration of 
compensatory liver growth have been only partially characterized. Recent studies have 
suggested that the Hedgehog pathway is a crucial mediator of accelerated liver regeneration 
triggered by ALPPS.7 Hedgehog is a secreted protein that regulates cell fate of different cell 
targets in a concentration- and duration-dependent manner.8 Mammals synthesise three 
different Hedgehog ligands: Sonic (SHH), Indian (IHH) and Desert (DHH) hedgehog. While 
SHH and IHH proteins are ubiquitously expressed, DHH expression is restricted to brain and 
testis.8 Growing evidence indicates that Hedgehog pathway is a critical regulator of adult liver 
repair and regeneration.7,8 Animal models of liver regeneration present transient activation of 
Hedgehog pathway. Moreover, administration of recombinant IHH accelerates liver 
regeneration and improves outcome. Notably, both patients and animal rodents subjected to 
ALPPS also show an increase in the circulating levels of IHH that associates with 
accelerated compensatory liver growth.7,8 The fundamental question is: what does support 
elevated and, more important, sustained levels of Hedgehog ligand during liver 
regeneration?   
 
In this issue of Journal of Hepatology, Langiewicz and colleagues [9] presented a very 
intuitive study addressing the complexity in the molecular mechanism of Hedgehog signal 
production in regenerating livers followed by ALPPS. By performing differentiated gene 
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expression analyses in ALPPS mouse livers the authors demonstrated that ALPPS livers had 
elevated mRNA expression of Mapk8 (JNK1) compared to appropriate surgery controls.9 
Importantly, similar to Hedgehog protein, both JNK1 (not-phosphorylated) and 
phosphorylated-JNK (active-JNK) levels were also highly detected in hepatic lysates post-
ALPPS.9 These similarities led the authors to investigate a putative link between JNK and 
Hedgehog pathways. The c-Jun N-terminal kinase (JNK), an evolutionarily conserved 
mitogen-activated protein kinase (MAPK), is one of the crucial signalling pathways that 
regulate cell proliferation, survival and cell death.10-12 Notably, phospho-active JNK co-
localised with IHH in activated hepatic stellate cells, specialised cells that exist in the space 
between parenchymal cells and sinusoidal endothelial cells of the hepatic lobule (Figure 1). 
This co-localisation was also associated with IHH downstream effector GLI1 and its 
proliferative target cyclin D1, adding support to a putative link between cell proliferation and 
JNK-IHH axis (Figure 1).9 
 
To establish a direct link between JNK, IHH and accelerated hepatic regeneration following 
ALPPS, Langiewicz et al. pre-treated mice with SP600125 JNK inhibitor13 and analysed liver 
regeneration following ALPPS hepatic resection. Compared to JNK inhibited livers, control 
mouse livers regenerated more rapidly following ALPPS, suggesting that JNK is crucial for 
ALPPS-mediated acceleration of liver regeneration. Remarkably, SP600125-trated mice 
showed diminished levels of GLI1, cyclin D1 and other tissue proliferative markers.9 
Altogether these data represent the first step linking JNK activation to Hedgehog signalling in 
regenerating livers (Figure 1), although genetic validation to strength this link in regenerating 
livers would be necessary. As the authors discussed, the use of pharmacological inhibition of 
JNK is a limitation to the study. Above all, SP600125 can bind to a broad range of protein 
kinases (including other MAPKs such as p38-MAPK and ERK-MAPK) and inhibit some of 
them with similar or greater potency than JNK.14,15 In addition, SP600125 does not 
discriminate between JNK1 and JNK2, the two ubiquitously expressed JNK proteins coded 
by two distinct JNK genes: Mapk8 (Jnk1) and Mapk9 (Jnk2).13 Indeed, recent studies have 
demonstrated that the JNK proteins differ in function especially in liver regeneration. Mice 
deficient in Jnk1 display impaired liver regeneration following two-thirds partial 
hepatectomy.10,16 Less clear is, however, the role of JNK2 in liver regeneration. While one 
study demonstrated that the loss of JNK2 accelerated liver regeneration,17 another more 
recent study reported no role for JNK2 in liver regeneration.18 Moreover, mice deficient in 
growth arrest and DNA-damage-inducible gene 45β (GADD45β) have reduced hepatocyte 
proliferation and increased apoptosis associated with sustained activation of JNK following 
two-thirds partial hepatectomy.19 Importantly, disruption of Jnk2 increased liver regeneration 
in Gadd45β-/- mice, indicating that the magnitude and duration of JNK activation is relevant 
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in regenerating livers.19 Therefore, the use of genetically engineered JNK1 (and/or JNK2) 
mice, along with in-vivo analyses of SP600125 treated livers, would have given a direct 
evidence of the involvement of JNK signalling in the acceleration of hepatic regeneration 
following ALPSS hepatic resection.  
 
What’s intriguing is that restoring IHH signal reinstated the regenerative response in 
SP600125-treated mice after ALPPS hepatic resection. With a clinically relevant approach, 
Langiewicz and colleagues [9] have indeed showed that administration of recombinant IHH 
ligand (rIHH) compensates for the inhibition of JNK in SP600125-treated, ALPPS resected 
mice. Importantly, rIHH administration restored the hepatic levels of GLI1 and cyclin D1 (lost 
after SP600125 treatment) and, consequently, livers had more Ki67-postive hepatocytes and 
other mitotic figures than control groups. Surprisingly, rIHH treatment not only restored liver 
regeneration but also increased the nuclear levels of both JNK and phospho-JNK suggesting 
that a positive feedback loop exists for IHH in regulating levels of JNK in ALPPS 
regenerating livers. Mechanistically, the authors presented a very plausible explanation in 
which IHH enhances JNK levels that favours sustained JNK activation needed to maintain 
elevated levels of IHH during liver regeneration (Figure 1)9.  
 
Although the described feed forward mechanism would need further evidence, a similar 
mechanism has been suggested in a model of injury-stimulated Hedgehog signalling in the 
regeneration of the Drosophila midgut.20 In this latter study, the authors hypothesise a similar 
feed forward mechanism whereby midgut injury favours JNK activation which drives 
Hedgehog-mediated proliferation of intestinal stem cells.20 Moreover, the ectopic 
supplementation of Hedgehog in the Drosophila midgut leads to JNK pathway activation with, 
yet, unclear mechanisms.20 It will be interesting to explore the mechanisms behind the 
complex relationship between JNK and Hedgehog signalling pathways during tissue 
regeneration. 
 
To summarise, Langiewicz and colleagues’ work documents a functional link between JNK 
activation and Hedgehog signal pathways during liver regeneration after ALPPS and 
suggests that compounds that stimulate the JNK1-IHH pathway may enhance the outgrowth 
of liver cell populations (including progenitor cells) and trigger tissue remodelling and 
promote accelerated liver regeneration. 
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Figure Legends 
 
Figure 1. The simplified representation of the crosstalk between the Hedgehog and 
JNK signalling pathways. Schematic drawing of the mechanisms of accelerated liver 
regeneration triggered by ALPPS hepatic resection. At the microscopic level, the liver 
consists of functional units called lobules, which are made mostly of hepatocytes (the most 
common type of liver cell), sinusoidal endothelial cells, biliary epithelial cells, Kupffer cells 
and hepatic stellate cells. Hepatic stellate cells and Kupffer cells closely interact with 
hepatocytes supporting cytokines and growth factors production needed for hepatocyte 
growth and survival. Following an injury or resection, the liver responds to reinstate the 
original mass by stimulating cellular proliferation. In the model described by Langiewicz and 
colleagues’ study [9], the authors propose a model whereby ALPPS-mediated liver 
regeneration is mediated by the accumulation of JNK in hepatic stellate cells. Nuclear active-
JNK is then associated with an increase in of IHH ligand expression levels, which can be 
released by the hepatic stellate cells in the hepatic sinusoidal space. Circulating IHH ligand is 
intercepted by receptors exposed on the surface of hepatocytes and stimulates hepatocyte 
proliferation through the transcriptional activation of the IHH downstream transcription factor 
GLI1, which regulates the gene expression of the cell cycle regulator cyclin D1. 
Administration of SP600125 JNK inhibitor blocks activity of JNK with consequential reduction 
of IHH levels and hepatic regeneration. Surprisingly, administration of recombinant IHH 
ligand restores the nuclear levels of both JNK and active-JNK in SP600125-treated livers, 
suggesting that a positive feedback loop (dotted lines) exists for IHH in regulating levels of 
JNK in ALPPS regenerating livers. The mechanisms underlying the proposed model are, 
however, unclear. 
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